FDA Clears Vera Therapeutics Kidney Drug Trutakna for IgA Nephropathy

By Adam Feuerstein · STAT News · 2026-07-07

The Food and Drug Administration has granted approval to Vera Therapeutics for its new autoimmune treatment, Trutakna. According to STAT News, the therapy targets patients suffering from IgA nephropathy, a condition where antibody accumulation causes progressive kidney damage and

The Food and Drug Administration has granted approval to Vera Therapeutics for its new autoimmune treatment, Trutakna. According to STAT News, the therapy targets patients suffering from IgA nephropathy, a condition where antibody accumulation causes progressive kidney damage and